Chapter 20: Using Evidence to Influence Health and Organizational Policy

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Imagine you just finished this, like, totally grueling 12 -hour nursing shift.

Oh, the worst.

Right.

You are physically exhausted, you are emotionally drained, and you are so ready to just hand off your patients and go home.

Absolutely.

But your manager blocks the door and tells you that because of staffing shortages, you are legally required to stay and work another six hours.

Mandatory overtime.

Yeah.

Exactly.

And you know the science, like, you know the clinical evidence says your fatigue will inevitably cause medical errors, but, and here's the real issue, how do you prove that to a lawmaker sitting in a state capitol who has, you know, never even worn a pair of scrubs?

Yeah, that scenario right there.

That is the exact friction point where clinical reality just crashes headfirst into the legal system.

It's intense.

It really is.

Because, I mean, as a health sciences professional, you're taught that healthcare is this beautifully insulated clinical bubble.

You follow the science, you apply the evidence -based practice guidelines, and you fix the patient.

Right.

It's very linear, very clean.

Exactly.

But then you zoom out, you step outside those hospital doors, and that clean linear science collides with the incredibly messy non -linear world of, you know, human behavior and budgets and legislation.

And that is exactly what we are tackling today.

So if you are a nursing or health sciences student gearing up to conquer evidence -based practice or EBP, this deep dive into the source material is literally custom -built for you.

It really is.

Because our mission today is to take the core concepts from Chapter 20 of evidence -based and nursing and healthcare, the fifth edition, and really show you how EBP extends way beyond the bedside.

Way beyond.

Yeah.

We are exploring how you can use evidence to actually influence health policy at the macro government level and also organizational policy at the micro hospital committee level.

So let's unpack this right out of the gate, because we are talking about policy, but the text makes a really specific distinction between health policy and healthcare policy.

What is the actual difference there?

Right.

So the difference really lies in the ultimate target.

So health policy is incredibly broad.

It seeks to affect overall population health.

Like public health stuff.

Exactly.

Think about sweeping laws regarding clean water standards or mandatory seat belts or even federal funding for public health initiatives.

That's health policy.

Okay.

Got it.

Now, healthcare policy is much more targeted.

It focuses on the delivery mechanisms.

So things like improving health equity,

expanding access to care, and governing the actual quality of the healthcare services themselves.

Okay.

Wait.

Let me push back here for a second though.

Sure.

Because mixing politics with clinical science just sounds, I mean, it sounds incredibly dangerous.

If we start bending biological facts to fit a state budget or some political agenda, aren't we fundamentally failing the patient?

Like shouldn't science and politics stay completely separate?

Honestly, that is a totally valid fear and it's an incredibly common feeling among clinicians.

Yeah, I'd imagine.

But there is this great quote in the text by Madeleine Lubin Finkel that addresses this head on.

She basically argues that pretending politics and science do not coexist is foolish.

And cleanly separating science from politics is probably neither feasible nor recommended.

Foolish.

Wow.

That's a strong word.

It is.

But when you look at how hospitals are actually funded and how they're regulated, it just makes sense.

You can't separate them.

So OK, since science and politics must mix, how on earth does our clean clinical EDP model

survive the, well,

the chaotic world of politics?

Well, the short answer is the clinical model has to adapt.

The reality is that public policy is rarely driven purely by clinical evidence.

Right.

It's driven by partisanship, the diverse values of all these competing stakeholders,

massive budget constraints, public opinion, and, you know, the media cycle.

The text actually uses the COVID -19 pandemic as a perfect example of this clash.

And just to be super clear to everyone listening, we are just looking at the friction points of the policy process here.

We're not endorsing any specific mandates.

But that friction was undeniable, right?

Oh, absolutely undeniable.

During the early days of the pandemic,

scientific evidence was evolving rapidly, like sometimes daily.

Yeah, it was crazy.

But that rapid scientific evolution completely clashed with a complex, really inflexible policymaking environment.

So we saw this massive gap between what emerging scientific evidence suggested and the policies that were actually enacted.

Just because legislation cannot pivot as fast as a virus mutates?

Exactly.

You hit the nail on the head.

Which brings us to a massive terminology shift in the chapter.

Because of this messy reality, we actually no longer use the term evidence -based policy.

Right.

The new global standard is evidence -informed health policy, or EIHP.

Evidence -informed.

I really love that distinction.

The analogy that comes to mind is that, like, clinical EBP is like using a GPS on a paved highway.

Oh, I like that.

Right.

The evidence tells you exactly where to turn, and you just follow it directly to the patient's bedside.

But EIHP, like navigating politics, is more like using a compass in a dense jungle.

The evidence doesn't give you turn -by -turn directions.

It just points to true north to help inform or influence or mediate the dialogue among all these different stakeholders.

That is a brilliant way to conceptualize the shift.

Because if you walk into a political environment and rigidly demand that a policy be completely evidence -based, while just ignoring all the other factors like municipal budgets or voter values, your legislation will inevitably get derailed.

You'll just get laughed out the room.

Pretty much.

You must use the evidence to inform the dialogue, not dictate it.

So if the environment is a jungle, we clearly need to upgrade our tools.

How does the traditional EBP framework adapt to become this new EIHP model?

Because the chapter lays out three main components in Table 20 .1 that get a major upgrade.

Yeah, let's walk through those.

The first component is external evidence.

In clinical EBP, this is basically just your peer -reviewed research in clinical trials.

But in EIHP, you have to add relevant government and private data sources to that body of evidence.

Because lawmakers need macro -level population data, demographic statistics, economic impact reports.

They need all of that, not just a randomized controlled trial of 50 people.

That makes total sense.

Now, the second component in that table is internal evidence.

Clinically, this usually means your own bedside expertise and local quality improvement data from your specific hospital floor.

How does that change?

So in the EIHP model,

internal evidence shifts to what we call issue expertise.

Issue expertise.

This means adding data from professional associations like, say, your state nurses' association and leveraging the healthcare organization's broader historical experience with a specific policy issue.

So it's much bigger.

Exactly.

You are bringing the collective institutional expertise of an entire profession to the negotiating table, not just one nurse's experience.

Got it.

And the third component in clinical EBP is patient preferences and values.

But the chapter explains that in EIHP, this broadens out to stakeholder values and ethics.

So instead of treating one patient in a bed, our patient is now an entire population of stakeholders.

You are suddenly treating the system itself.

And you know, stakeholders is a massive umbrella term.

Right.

Who does that include?

It involves the policymakers writing the law, the healthcare consumers affected by it, consumer protection advocacy groups, and even the government agencies that will eventually be responsible for enforcing the policy.

Wow.

Yeah.

You are forced to consider the ethics, values, and limitations of everyone from a local lawmaker to the everyday citizen.

OK.

Here is where the methodology gets really interesting to me.

Now that we know what evidence we are looking for in this jungle, how do we actually search for it?

Well, we use an eight -step process for EIHP, which actually beautifully mirrors the standard EBP steps but applies them to legislation.

OK.

So it starts at step zero, right?

Right.

Step zero, which is cultivating a spirit of inquiry within the policy culture.

This means creating an environment where professionals are constantly asking, is this law actually producing the best health outcome?

And from there, we move to step one, which is asking the clinical question.

Now, any nursing student listening knows we use the PIACOT format for this.

Oh, absolutely.

Let's do a rapid refresher so everyone is on the same page.

P is population, I is intervention, C is comparison, O is outcome, and T is time.

But the chapter gives the P a major twist for policy, doesn't it?

It really does.

We still use PIACOT, but the population of interest is no longer just,

say, adult patients with diabetes.

It is now the representative consumer population that will be affected by the health policy.

OK.

And my absolute favorite part of the chapter, like my big aha moment, was how you can actually use a PIACOT question completely backward.

Yes.

This is so cool.

Normally, you use PIACOT to drive a brand new literature search, but the text says you can use it to deconstruct pending or existing policy.

It's an incredibly powerful analytical tool for students to master.

So if I'm looking at this dense 40 -page piece of legislation about, let's say, telehealth expansion, I can use PIACOT backward to say, OK, who is the exact population this affects?

Rural patients.

What is the intervention?

Subsidized broadband.

What is the outcome they want?

Decreased ER visits.

Exactly.

It acts like a decoder ring for all that legal jargon.

It lets you analyze the component parts of a law so you can scrutinize it against the evidence.

And if you are wondering where to find these policies to deconstruct, the chapter points you to a few key places.

For federal legislation, govtrack .us tracks everything in the U .S.

Congress.

Very handy.

Yeah.

And for state -level issues, you want your state legislature websites, which often house legislative summaries and even public hearing testimony.

And importantly, for nursing students, your state boards of nursing are just crucial resources for analyzing regulatory policies.

Absolutely.

So then we move through the rest of the eight steps.

Step two is searching for the evidence.

Step three is critically appraising it to make sure it's valid.

Step four is integrating it.

Step five is contributing to the policy development.

Step six is implementation.

And step seven is evaluating the outcomes and disseminating the findings.

OK.

But when it comes to policy, timing is everything.

When do we actually share this evidence with the lawmakers?

So unlike clinical EBP, where dissemination usually happens at the very end of a study,

EIHP actually has two distinct dissemination windows.

Two windows.

The first window happens early in the process, during steps four and five, which is integrating the evidence and developing the policy.

So this is happening while the policy is still being written and debated.

Exactly.

This early dissemination usually happens behind the scenes.

It takes place in task force meetings or closed -door negotiations with bill sponsors or public committee hearings.

The goal here is to use your body of evidence as leverage to shape the dialogue before the ink on the law is even dry.

Let's go back to that exhausted nurse from our intro.

The chapter gives a really intense real -world example of this early dissemination involving mandatory overtime.

Yeah.

It's a great example.

A state nurses' association was providing testimony to support a bill that would legally prevent employers from forcing fatigued nurses to work mandatory overtime.

Which is huge.

Huge.

And the nurses provided compelling internal evidence, you know, stories of nurses being forced to work half a shift right after finishing a 12 -hour shift, actual threats to their employment.

And they combine that with external literature on how provider fatigue directly causes patient mortality and medical errors.

But the legislators pushed back.

Like, they didn't just accept the stories.

No, they wanted more evidence.

They asked for data specifically comparing the error rates of eight -hour versus 12 -hour shifts.

Wow.

They wanted to see staffing models from other high -reliability organizations, like aviation, to see how pilots manage fatigue.

And shockingly, they even asked for the actual redacted email showing employers threatening the nurses.

That is wild.

It just highlights that in that early window, you have to be ready to provide a mountain of robust, varied evidence to leverage the change you want.

Exactly.

So what about the second window for dissemination?

Right.

So the late dissemination window happens during Step 6 and 7.

This is post -implementation.

The policy has already been enacted, and now you are notifying the public of the new rules or evaluating the findings.

And the example the chapter gives for this affects almost every clinician practicing today.

It's the Ohio Acute Pain Prescribing Regulations.

Let's dive into the why and how of this, because it's so relevant.

It really is.

When you look at the historical context, back in the early 2000s, pain was introduced as the fifth vital sign.

Right.

And this cultural shift led to a massive increase in prescribing opioids, which directly fueled a devastating national crisis.

The evidence eventually caught up, and new evidence -based guidelines called for drastic reductions in opioid prescribing.

So Ohio's governor didn't just write a law blindly.

He tasked a massive interprofessional group, the state boards of nursing, medicine, and pharmacy, to synthesize this new evidence and create strict limits.

Exactly.

They had to comb through the clinical data showing that massive upfront prescriptions for minor procedures were a primary gateway to addiction.

And then they translated that clinical evidence into a sweeping legal mandate.

And then disseminated it.

Right.

The resulting policy, which was widely disseminated to the public and providers during Step 7, put strict boundaries on advanced practice registered nurses.

What were the actual limits they implemented?

Do you remember?

Yeah, it instituted a seven -day maximum for adult acute pain prescriptions and capped the maximum total morphine -equivalent dose, or MED, at 30 per day.

30?

Yeah.

This is a perfect example of late dissemination, taking a massive body of clinical evidence, turning it into a regulatory boundary, and broadcasting it to every licensed provider in the state.

Okay.

So we know when to deliver the message, but how do you actually hand this information to a politician without their eyes immediately glazing over?

Like, if you only have three minutes with a state senator in a hallway, how do you deliver the evidence?

You use the ultimate policy tool,

the one -page policy brief.

It's often called the elevator speech.

Box 20 .1 breaks this down.

And the formatting rules here are ruthless, but they are crucial because lawmakers read hundreds of these a day.

It must be strictly one -page.

Yes.

One -sided.

Bullet points only.

If it bleeds onto page two, it might as well not exist.

Exactly.

You have to clearly state your organization's position right at the top.

Are you a proponent, an opponent, or an interested party?

And you also want to include compelling visuals like simple tables or bar charts if you have them.

But the absolute most critical rule for the policy brief,

banish all medical jargon.

Yes.

Oh my gosh.

Yes.

You have to explain things clearly using lay terminology.

I mean, a senator does not need to know the cellular receptor mechanism of a pain drug.

They need to know how that drug impacts the addiction rates of the constituents in their district.

Know your audience.

The second delivery method the chapter outlines in table 20 .2 is much more formal, giving testimony at a public hearing.

Okay.

Stressful.

Very.

Imagine you are sitting in a microphone.

The chairperson is looking right at you.

And you have to defend your evidence on the record.

There are crucial do's and don'ts for this environment.

Walk us through the do's first.

Do analyze your audience beforehand.

Know who the chairperson of the committee is and research whether any lawmakers on the panel actually have health care backgrounds.

That's smart.

Very.

Also, do bridge the external statistical editors with your own clinical stories that internal issue expertise to make the data feel real and urgent to them.

And always, always provide a comprehensive reference page as an appendix to your testimony.

And the don'ts.

Never cite individual research studies in your speech.

Lawmakers don't want to hear about one isolated trial of 20 people.

You must focus on the body of evidence and the overarching consensus.

Furthermore, don't get defensive or emotional.

Even if a lawmakers questioning becomes aggressive or dismissive.

Let's role play this for a second because this is terrifying.

Okay, let's do it.

Let's say I'm a nursing student.

I'm testifying for the very first time and a representative asks me a highly specific statistical question about my evidence.

My instinct is to freeze, look at my shoes and just say, uh, I don't know.

Right.

And the chapter is very explicit that you must never do that saying I don't know kills your credibility instantly.

Oh man.

So what do I say?

Instead, the protocol is to confidently say that's a great question.

I will be happy to find out and get back to you.

Oh, that sounds so much more professional and it keeps you in control of the conversation.

It does.

But, and this is a big, but the key to maintaining that credibility is the follow through.

You must ensure you actually consult your resources and get back to their office with the correct answer within 24 hours.

Wow.

24 hours.

Okay.

That is such a great practical tool for anyone stepping into advocacy.

Now let's pivot slightly because reality is not every student listening to this is going to end up testifying before Congress, but every single health sciences professional will eventually work in a healthcare organization.

So how do we apply this EIHP mindset to the hospital you work in?

Yeah.

So now we are shifting gears to the micro level of EVP.

This is about organizational policy and procedure committees.

Table 20 .3 covers this.

These are the interprofessional teams made up of nurses, pharmacists, respiratory therapists, administrators, who literally write the standard operating procedures for patient care on the hospital floor.

So if I'm a new nurse and I join one of these hospital committees, how do I actually champion EVP?

The chapter provides a step -by -step enculturation program for these teams to make evidence the standard.

So step one is formulating that PI -COT question for whatever hospital policy is up for review.

But step two highlights a vital, often overlooked resource, securing a medical librarian.

Why a librarian specifically?

I feel like people always overlook them.

Oh, they are lifesavers.

A medical librarian can teach the committee advanced literature search skills.

They help the team identify the correct, highly specific keywords generated from those PISIL questions, ensuring you aren't wasting hours sifting through totally irrelevant journals.

That saves a massive amount of time.

Huge.

And then we hit step three, which the text explicitly notes is the most challenging part of the entire process.

Building critical appraisal skills.

Explain why this is such a roadblock.

Think about the makeup of these committees.

You often have veteran nurses with 20 years of incredible bedside experience.

But they may have graduated before EBP and statistical appraisals were standard parts of the nursing curriculum.

Oh, I see.

So staring at complex statistical analyses and P values can make highly competent professionals feel deeply intimidated.

It's like a form of imposter syndrome.

Exactly.

So how do we fix that?

How do we help them critically appraise the research without needing a math degree?

The best practice outlined in the chapter is to create synthesis of evidence tables.

I really love the phrasing the text uses for this.

It says these tables anchor the policy to the evidence.

What does one of these tables actually look like?

It's basically a visual tool.

It strips away the statistical noise.

You create columns for the study, columns for the specific findings, and columns linking those findings directly to the proposed change in hospital protocol.

Oh, that's brilliant.

It visually proves the math.

You aren't just changing a hospital rule because a manager felt like it.

You have a physical document proving exactly why the new protocol is safer for the patient.

That is so clear.

And then in steps five and six of the enculturation process, you must incorporate that new EBP into the hospital's quality improvement or QI processes.

You have to track if the new policy actually improved patient outcomes on the floor and then disseminate those outcomes widely on the organization's website, in staff meetings, everywhere.

Yeah.

And I mean, this all sounds incredibly efficient in theory, but we have to acknowledge the reality of human nature.

People do not like change.

No, they don't.

When you actually try to change the culture of a hospital committee, you are going to hit walls.

The chapter is wonderfully realistic about this, outlining three major organizational roadblocks.

The first is simply time.

Hospitals usually require every single internal policy to be reviewed at least every three years.

If your hospital has hundreds of policies, that is a mountain of paperwork.

A literal mountain.

And while the hospital might pay you for the hour you sit in the committee meeting, they rarely give bedside staff protected paid time away from patients to do the massive literature searches required to actually update the evidence.

It is a huge friction point.

The second roadblock, which we touched on with the synthesis tables, is skill variations.

You have that mix of newly graduated EBP trained nurses sitting next to veteran clinicians who lack confidence in the critical appraisal process.

Right.

And the third major roadblock is membership turnover.

If you spend a year getting a committee fully trained and comfortable with EBP, and then three of those people leave for different hospitals, you're back to square one.

Unless you have a system.

Exactly.

Unless you have a formal structured orientation process in place for new committee members.

So with all these roadblocks, lack of time, fear of statistics, constant turnover, what is the solution?

How do we actually make EBP enculturation survive?

The chapter points to one foundational concept,

transformational leadership.

If the hospital leadership doesn't actively buy in, the culture simply won't change.

The text describes these transformational leaders very clearly.

They are EBP positive role models.

They don't just mandate evidence.

They actively collaborate with academic nursing programs to bring in fresh expertise.

They use external EBP experts to mentor the floor staff.

And most importantly, they establish a psychologically safe environment where clinicians are encouraged to ask why we do things a certain way without fear of reprimand.

They are the ones who make EBT stick.

And when you connect this back to our overarching mission today,

the fundamental mechanism is exactly the same.

Well, whether you were trying to change a state law about nurse overtime in the Capitol or trying to change a hospital protocol for pain management on the fourth floor, you are leveraging the best available evidence to improve human outcomes.

That's a great way to look at it.

Let's quickly recap this incredible journey.

We started by exploring why clean clinical EBP has to pivot into Evidence Informed Health Policy, or EIHP, to navigate the messy jungle of politics.

We learned how to use a PCOT question backward to reverse engineer and decode a 40 -page law.

Such a good tool.

Right.

We went over the golden rules of the one -page elevator speech—no jargon, clear visuals, one -side only—and we brought it all home by looking at how to champion EBP enculturation on your hospital's procedure committee using synthesis tables and transformational leadership.

As we wrap up this chapter, I really want to leave you with a final thought to mull over.

OK, let's hear it.

As a student, you are spending countless hours mastering how to care for the single patient sitting in the exam room in front of you, and that bedside care is vital.

But looking at the evidence we discussed today, from mandatory overtime protections for fatigue nurses to opioid -prescribing limits that address a national crisis, ask yourself this.

How many thousands of patients could you protect over the course of your career if you learn to treat the policy as your patient?

Treat the policy as your patient.

That is a really powerful perspective shift.

Because whether you are a clinician on the floor treating a single injury or the person writing the rulebook to make the entire system safer, you are still saving lives.

Exactly.

To you, the student listening right now, thank you.

Thank you for studying hard, for digging into the evidence, and for caring so deeply about the future of your practice.

You're going to do amazing things.

On behalf of the Last Minute Lecture Team, thanks for joining us on this deep dive.

Keep asking why, and we'll see you next time.